Harvard Bioscience (HBIO) Operating Leases (2019 - 2026)
Harvard Bioscience (HBIO) posted quarterly Operating Leases of $7.9 million for Q1 2026, up 9.42% year-over-year from $7.2 million in Q1 2025, and up 14.95% quarter-over-quarter from $6.9 million in Q4 2025.
Harvard Bioscience (HBIO) Operating Leases (2019 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Operating Leases for 8 consecutive years, with $7.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases rose 9.42% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $7.9 million (up 9.42% YoY), while the FY2025 annual figure was $6.9 million, up 7.85% from the prior year.
- Operating Leases rose to $7.9 million in Q1 2026 per HBIO's latest filing, from $6.9 million in the prior quarter.
- Across five years, Operating Leases topped out at $8.8 million in Q2 2025 and bottomed at $4.6 million in Q1 2024.
- Historically, Operating Leases has averaged $6.5 million across 5 years, with a median of $6.5 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Leases tumbled 41.21% — and 2025, when it jumped 58.66%.
- Harvard Bioscience's Operating Leases stood at $5.3 million in 2022, then declined by 9.24% to $4.8 million in 2023, then surged by 33.1% to $6.4 million in 2024, then increased by 7.85% to $6.9 million in 2025, then gained by 14.95% to $7.9 million in 2026.
- Business Quant data shows HBIO's Operating Leases at $7.9 million in Q1 2026, $6.9 million in Q4 2025, and $8.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.52 Mn |
| Mar 31, 2026 | 7.91 Mn |
| Dec 31, 2025 | 6.88 Mn |
| Sep 30, 2025 | 8.82 Mn |
| Jun 30, 2025 | 8.82 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 5.77 Mn |
| Mar 31, 2024 | 4.56 Mn |
| Dec 31, 2023 | 4.79 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Jun 30, 2023 | 4.65 Mn |
| Mar 31, 2023 | 4.94 Mn |
| Dec 31, 2022 | 5.28 Mn |
| Sep 30, 2022 | 5.54 Mn |
| Jun 30, 2022 | 7.91 Mn |
| Mar 31, 2022 | 7.91 Mn |
| Dec 31, 2021 | 6.49 Mn |
| Sep 30, 2021 | 8.84 Mn |